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Abstract 
A case of orofacial pain and inferior alveolar nerve (IAN) paraesthesia after extrusion of endodontic sealer within 
the mandibular canal treated with prednisone and pregabalin is described. A 36-year-old woman underwent root 
canal treatment of the mandibular second right premolar tooth. Post-operative panoramic radiograph revealed the 
presence of radiopaque canal sealer in the mandibular canal. Damage to IAN consecutive to extrusion of endodon-
tic sealer was diagnosed. Non-surgical management was decided, including: 1 mg/kg/day prednisone 2 times/day, 
once-daily regimen, and 150 mg/day pregabalin, two doses per day, monitoring the progress with periodic follow-up 
visits. Six weeks after the incident the signs and symptoms were gone. The complete resolution of paraesthesia and 
the control of pain achieved suggest that a non-surgical approach, combining prednisone and the GABA analogue 
pregabalin, is a good option in the management of the IAN damage subsequent to endodontic sealer extrusion.
Key words: Endodontics, inferior alveolar nerve, neuropathic pain, orofacial pain, paraesthesia, pregabalin.
Alonso-Ezpeleta O, Martín PJ, López-López J, Castellanos-Cosano 
L, Martín-González J, Segura-Egea JJ. Pregabalin in the treatment of 
inferior alveolar nerve paraesthesia following overfilling of endodontic 
sealer. J Clin Exp Dent. 2014;6(2):e197-202.
http://www.medicinaoral.com/odo/volumenes/v6i2/jcedv6i2p197.pdf
Article Number: 51420                http://www.medicinaoral.com/odo/indice.htm
© Medicina Oral S. L. C.I.F. B 96689336 - eISSN: 1989-5488
eMail:  jced@jced.es
Indexed in:
Pubmed
Pubmed Central® (PMC)
Scopus
DOI® System
doi:10.4317/jced.51420
http://dx.doi.org/10.4317/jced.51420
Introduction
Injuries of the inferior alveolar nerve (IAN), represent 
a rare but serious complication of dental treatment (1). 
Overinstrumentation during root canal treatment with 
manual or rotary instruments can perforate the mandibu-
lar canal. This allows the extrusion of endodontic seal-
ers, dressing agents, and irrigation solutions out of the 
tooth and into the canal that may lead to IAN injury (2). 
Although small material extrusions are generally well 
tolerated by the periradicular tissues (3), clinical symp-
toms are disabling sensory disturbances such as pain, 
dysesthesia, paresthesia, hypoesthesia, and anesthesia, 
which have been reported after the extrusion of endo-
dontic materials into the mandibular canal. Almost all 
of the endodontic materials are neurotoxic at some level 
and are able to initiate a inflammatory process which 
causes damage to cells and might culminate in necrosis 
of the tissue (3,4,5,6,7,8,9). 
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with resolution of pain and paraesthesia after a non-sur-
gical approach, including treatment with prednisone and 
pregabalin.
Case Report
A 36-year-old woman requested dental attention to her 
dentist. The main complaints were pain and swelling in 
the right mandibular second premolar (#45). Panoramic 
radiograph revealed widening of periodontal ligament 
space in the root apex of the affected tooth (Fig. 1). Acute 
apical periodontitis subsequent to caries was diagnosed 
and root canal treatment was carried out. One day af-
ter endodontic treatment, the patient had severe pain in 
the treated tooth and numbness on the right side of the 
lower lip that extended from the mandibular midline to 
the second premolar. Her dentist prescribed ibuprofen 
during one week, but after that time, pain and paresthe-
sia persisted, without any kind of improvement. The ex-
traction of the right mandibular second premolar tooth 
was decided. Two weeks after extraction, pain had not 
completely disappeared, and paresthesia remained. Pan-
oramic radiograph showed radiopaque material within 
the mandibular canal (Fig. 2). The dentist diagnosed 
Paresthesia might be caused by several factors, both lo-
cal and systemic. Local factors are, for example, the use 
of local anesthetics, trauma, local infections, neoplasia, 
tooth extraction, and endodontic related complications. 
Systemic factors are, for example, microbial infections, 
multiple sclerosis, lymphoma, or diabetes mellitus (4, 
10).
The normal therapeutic sequence for injuries to IAN is 
the control of pain and inflammation and, whenever pos-
sible, the surgical elimination of the cause (11). How-
ever, total resolution of pain and reduction or disappear-
ance of paraesthesia after a non-surgical management 
have been reported (3,7,8,9,12).
Pregabalin is a GABA analogue with similar structure 
and actions to gabapentin. It has antiepileptic, analgesic 
and anxiolytic activity. Its ability to reduce neurotrans-
mitter release from activated neurons in pain pathways 
and fear circuits may contribute to its role as an adjuvant 
in pain management and as anxiolytics. Pregabalin has 
proven effect in chronic and neuropathic pain (13-15).  
The aim of this paper is to describe a case of endodontic 
sealer penetration within the mandibular canal after root 
canal treatment of a mandibular right second premolar, 
Fig. 1. Panoramic radiograph revealed widening of periodontal ligament space in the root apex of 
the right mandibular second premolar.
Fig. 2. Panoramic radiograph revealing the presence of radiopaque material (endodontic sealer) 
within the mandibular canal. Tooth 45 has been extracted. 
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neuropathic pain and inferior alveolar nerve paresthesia 
after extrusion of endodontic sealer and then, decided to 
refer the patient to the University Dental Clinic. 
The referring dentist communicated that the root canal 
treatment was done with adequate anaesthesia and isola-
tion with rubber dam. The endodontic access cavity was 
prepared with round diamond burs, Komet 014 (Gebr. 
Brasseler GmbH, Lemgo, Germany). One canal orifice 
was found. Apical patency was carried out, and working 
length was determined electronically using Dentaport 
ZX (J. Morita Mfg. Corp. Higashihama Minami-cho, 
Fushimi-ku, Kyoto, Japan). The root canal was irrigated 
with 0,2 % chlorhexidine (CHX) and instrumented with 
Reciproc R25 (VDW GmbH, Munich, Germany). Af-
ter cleaning and shaping, the canal was dried and filled 
with AH Plus Jet (Dentsply DeTrey GmbH, Konstanz, 
Germany) and gutta-percha, using the lateral compac-
tion technique. A small quantity of sealer was introduced 
into the root canal using an intra-oral adjustable tip at-
tached with this sealer. Then the main gutta-percha cone 
was placed, coated with a minimal quantity of sealer. Cold 
compaction was had performed with a digital spreader 
and auxiliary gutta-percha cone which was covered with a 
small quantity of sealer.
The anaesthetized zone in the region innervated by the 
right inferior alveolar nerve was delimited by tactile ex-
ploration with an explorer (Fig. 3). Neither buccal gin-
gival tissues nor the lower lip between the midline and 
the second premolar showed sensitivity to thermal or 
mechanical stimuli.
regimen on a daily basis, and 150 mg per day of pre-
gabalin (Lyrica®, 75 mg; Pfizer SL, Barcelona, Spain), 
two doses by day, monitoring the progress with periodic 
follow-up visits. 
The patient noticed a significant improvement in the 
first days after the medical treatment. One week later, 
the patient had no pain, and paraesthesia in the region 
of the right lower lip had decreased more than half of 
its surface. The prednisone was stopped but the prega-
balin regimen was maintained. Three weeks later, the 
paraesthesia was reduced substantially compared with 
the initial situation (Fig. 4) and pregabalin treatment was 
finished. Panoramic radiograph was taken, revealing a 
significant reduction in the amount of endodontic sealer 
within the mandibular canal (Fig. 5, Fig. 6). The patient 
reported a gradual reduction of paraesthesia and after six 
weeks signs and symptoms had disappeared.
Fig. 3. Three weeks after the accident during the root canal 
treatment, a delimitation of the mental nerve anaesthesia is 
performed. 
After discussing treatment options with the patient, 
who refused surgical debridement of the mandibular 
canal and decompression of the inferior alveolar nerve, 
a non-surgical approach was therefore decided. Treat-
ment started with anti-inflammatory regimen including 
1 mg/kg/day of prednisone (Dacortin®, 30 mg; Merck 
SL, Madrid, Spain) in two doses, in a gradually reducing 
Fig. 4. Three weeks after treatment with pregabalin and predni-
sone the area of mental nerve anaesthesia has decreased subs-
tantially.
Discussion
A case of neuropathic pain and inferior alveolar nerve 
paresthesia after extrusion of endodontic sealer within 
the mandibular canal has been described. Most of pub-
lished cases of paresthesia related to endodontics might 
be caused by overinstrumentation and/or overfill of en-
dodontic materials into the mandibular canal (1,10). IAN 
injuries have been reported in relation with endodontic 
treatment in second mandibular molars, because the dis-
tance between the apexes and the mandibular canal is of-
ten less than 1 mm. However, first molars and premolars 
must be also taken into consideration (11,16,17).
Overinstrumentation and/or overfilling of mandibular 
molar and premolar are a potential iatrogenic cause of 
IAN injury (18). Gutta-percha is traditionally considered 
an inert root-filling material, and the paresthesia cases 
involving gutta-percha usually result from overfill of 
thermoplastic gutta-percha. If the sealer is extruded in 
the mandibular canal space, it can cause problems that 
vary from mild inflammatory reactions to severe neuro-
toxic damage (11,19,20). 
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systemic diffusion through a periapical vein and pro-
gression toward soft tissues between bone and mucosal 
membrane (3,23). The case reported here corresponds 
with the first of these routes.
The first symptom of overextension into the mandibu-
lar canal is sudden pain during filling of the root canal, 
which persists after the disappearance of the local anaes-
thetic (24). The literature provides ample evidence that 
this might induce mild or serious transient inflammatory 
responses (25,26). Due to this, pain can be accompanied 
by local inflammatory signs with painful tooth to percus-
sion, painful upon palpation of the buccal alveolar proc-
ess or a combination of signs of mechanical trauma and 
inferior dental nerve inflammation with pain or numb-
ness of the lower lip or otalgia (27). Some patients expe-
rience persistent anaesthesia (1,10,28,29). In the present 
case, symptoms occurred after one day, and pain was 
associated with paraesthesia.
Damage by accidental extrusion of sealer into the man-
dibular canal may occur due to mechanical, thermal, 
or chemical processes (4,6,9,30). In the case described 
here, AH Plus Jet extruded into the mandibular canal. 
This sealer is commercialized as a syringe of automix, 
with a final cannula that introduces it into the canal. This 
sealer is commercially as a syringe of automix, with a 
final cannula that introduces it into the canal.  It is an 
open-end cannula, therefore it could be applied the same 
as the irrigation needles. Lots of bibliographic sources 
conclude that these have higher probability of apical ex-
trusion (31,32,33). Because of the use of this mechanism 
in the inclusion of cement on the root canal, it was able 
to facilitate its extrusion by the apex.
AH Plus Jet is a commonly used epoxy resin-based root 
canal sealer with the monomer 2,2-bis(4-(2-hydroxy-3
-methacrylyloxypropoxy) phenyl)-propane (BisGMA), 
prepared from bisphenol A and glycidyl methacrylate, as 
its major ingredient (34). Previous reports have shown 
that AH Plus can cause cytotoxic effects (35) and neu-
Severe endodontic pain after endodontic sealer extru-
sion requires early diagnosis and prompt management 
to reduce the risk of permanent nerve damage. Cone-
beam computed tomography (CBCT) is often useful in 
monitoring the area of tissue damage in relation to hard 
tissues (eg. the location of extruded material in relation 
to mandibular canal or mental foramen) (21,22).
The literature describes four possibilities of endodon-
tic sealer spreading to the periapical region: toward the 
mandibular canal, drainage through lymphatic vessels, 
Fig. 5. Panoramic radiograph after three weeks of treatment with pregabalin and prednisone. 
Fig. 6. A) Initial panoramic radiograph detail. B) Panoramic 
radiograph detail after three weeks of treatment. A significant 
reduction in the amount of endodontic sealer within the mandi-
bular canal is observed. 
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rotoxicity when extruded into the mandibular canal (8). 
Moreover, it has been shown that its component bisphe-
nol A can also cause cytotoxicity (36). The cytotoxic ef-
fect of AH Plus has been shown to be dependent on the 
setting time, showing a significant reduction after 7 days 
(37). In a recent study of the cytotoxicity of AH Plus, 
there was no evidence for DNA double-strand breaks 
caused; so far, there are no reports in the literature on the 
occurrence of periapical malignant lesions that might be 
caused by the extrusion of root canal sealer (38). 
In this case, polymerization of the sealer may explain, at 
least in part, the rapid improvement observed in the first 
days after the incident. Gutta-percha and sealers may 
cause both an inflammatory reaction and pain when ex-
truded beyond the root canal system. The nature and de-
gree of tissue reaction is related to the type and amount 
of sealer, the location of the extrusion, and the condi-
tion of periodontal tissues (30). Even root canal sealants 
that are believed to be more benign, such as zinc oxide, 
eugenol, and calcium hydroxıde (owing to high pH), 
have been shown to be neurotoxic in vitro and are more 
certainly neurotoxic in vivo (40). In some experimental 
studies it was shown that paraformaldehyde is a poly-
meric hydrate of formaldehyde, which when in contact 
with water releases formaldehyde gas, and may cause 
permanent damage to the nerve (41).
Treatment of this endodontic complication remains 
controversial, varying from a wait-and-see approach, 
including anti-inflammatory drugs and periodic follow-
up (3,7,8,9,12), to early, if not immediate, surgical deb-
ridement of the inferior alveolar nerve involving bone 
removal of the vestibular cortical plate (2,6,18) or sag-
ittal mandibulotomy (19). The patient refused surgical 
debridement of the inferior alveolar canal and decom-
pression of the inferior alveolar nerve, and decided to 
make the extraction of second lower right premolar. So, 
a non-surgical management was agreed including anti-
inflammatory treatment with prednisone and analgesic 
treatment with pregabalin.
Most of the pain treatments used for neuropathic pain 
have not been approved by FDA, including all the tri-
cyclic antidepressants and most of the anticonvulsants. 
Two medications are approved for peripheral neuropa-
thy by the FDA; duloxetine and pregabalin (42). In July 
2004 pregabalin was granted approval in all European 
member states for the treatment of peripheral neuro-
pathic pain. Pregabalin is an analogue of the inhibitory 
neurotransmitter gamma-aminobutyric acid (GABA). 
Although its main indication is chronic pain and trigemi-
nal neuropathic pain (14,43), it has been frequently used 
in neuropathic pain (44). Pregabalin has shown analge-
sic activity in preclinical and clinical models, observ-
ing a significant improvement as early as week 1 and is 
maintained throughout the period of treatment (45,46) 
and appears to have significant analgesic properties fol-
lowing third molar extraction (47). Peak plasma levels 
occur approximately 1 hour after oral doses and oral 
bioavailability is approximately 90%. Pregabalin is not 
protein-bound and exhibits a plasma half-life of 6 hours, 
which is not dose-dependent. These antiepileptic drugs 
have a favorable safety profile with minimal concerns 
regarding drug interactions and showing no interference 
with hepatic enzymes (48). Hepatic metabolism is neg-
ligible, and most of the oral dose (95%) is eliminated by 
renal excretion. Pregabalin is a safe and well-tolerated 
new treatment for neuropathic pain and the most com-
mon side effects included dizziness, and somnolence, 
peripheral edema, weight gain, and asthenia, but this 
finding was not reported in this case (13,49). Taking into 
account that endodontic sealer extrusion into the man-
dibular canal damages the inferior alveolar nerve trig-
gering neuropatic pain, the use of pregabalin in the case 
reported here was justified. 
The complete resolution of the paraesthesia and the 
control of pain achieved in the present case, suggests 
that a non-surgical approach combining prednisone and 
pregabalin is a good option in the management of in-
ferior alveolar nerve damage subsequent to endodontic 
sealer extrusion. If medical treatments have failed, in-
vasive therapies such as intrathecal drug administration 
and neurosurgical techniques may be considered.
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